Boai NKY Medical Holdings Ltd. (SHE:300109)
China flag China · Delayed Price · Currency is CNY
10.74
-0.25 (-2.27%)
Nov 6, 2026, 3:04 PM CST

Boai NKY Medical Holdings Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1951,1661,5881,5621,4491,196
Other Revenue
11.8811.8818.8120.9336.6623.94
1,2071,1781,6061,5831,4861,220
Revenue Growth
-16.55%-26.66%1.45%6.58%21.75%24.70%
Cost of Revenue
693.12639.06856.29689.03795.1732.99
Gross Profit
514.18539.04750.03894.39690.59487.28
Selling, General & Admin
172.46164.84206.41235.76188.03253.44
Research & Development
72.1373.571.5163.7165.7375.53
Other Operating Expenses
18.3710.0812.6913.979.611.45
Operating Expenses
284.25267.74317.26323.04309.18352.11
Operating Income
229.93271.3432.78571.35381.42135.17
Interest Expense
-3.16-7.59-7.04-2.07-2.62-37.73
Interest & Investment Income
1.3511.5936.9713.5923.53235.9
Currency Exchange Gain (Loss)
0.830.835.04-1.423.11-0.8
Other Non Operating Income (Expenses)
-25.3-8.93-7.51-3.37-6.45-7.41
EBT Excluding Unusual Items
203.65267.19460.24578.11418.99325.13
Impairment of Goodwill
-40.45-40.45-44.85---60.51
Gain (Loss) on Sale of Investments
-15.562.81-13.22-1.07-37.8314.15
Gain (Loss) on Sale of Assets
-3.432.460.090.04-0.87-0.46
Asset Writedown
-1.2-1.2-1.52-0.36-0.11-0.11
Other Unusual Items
9.645.60.528.638.299.91
Pretax Income
152.65236.41401.26585.36388.47288.1
Income Tax Expense
30.9850.6656.2599.57107.0493.27
Earnings From Continuing Operations
121.66185.75345.01485.79281.43194.82
Minority Interest in Earnings
2.174.344.677.2410.0312.22
Net Income
123.84190.09349.68493.03291.46207.05
Net Income to Common
123.84190.09349.68493.03291.46207.05
Net Income Growth
-48.30%-45.64%-29.07%69.16%40.77%364.49%
Shares Outstanding (Basic)
581585575563596582
Shares Outstanding (Diluted)
581585583580617601
Shares Change
-2.37%0.36%0.48%-6.03%2.67%4.93%
EPS (Basic)
0.210.330.610.880.490.36
EPS (Diluted)
0.210.330.600.850.470.34
EPS Growth
-47.04%-45.83%-29.41%80.01%37.11%342.67%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
148.82117.69-18.65110.37-14.23-184.88
Free Cash Flow Per Share
0.260.20-0.030.19-0.02-0.31
Dividend Per Share
0.1670.1670.2080.5550.2780.278
Dividend Growth
-19.78%-19.78%-62.59%99.96%0%2402.70%
Gross Margin
42.59%45.76%46.69%56.48%46.48%39.93%
Operating Margin
19.05%23.03%26.94%36.08%25.67%11.08%
Profit Margin
10.26%16.13%21.77%31.14%19.62%16.97%
Free Cash Flow Margin
12.33%9.99%-1.16%6.97%-0.96%-15.15%
EBITDA
331.37373.01534.87645.57443.36207.05
EBITDA Margin
27.45%31.66%33.30%40.77%29.84%16.97%
D&A For EBITDA
101.44101.72102.0974.2261.9471.88
EBIT
229.93271.3432.78571.35381.42135.17
EBIT Margin
19.05%23.03%26.94%36.08%25.67%11.08%
Effective Tax Rate
20.30%21.43%14.02%17.01%27.55%32.38%
Revenue as Reported
226.591,1781,6061,5831,4861,220
Advertising Expenses
-2.041.090.610.583.81